Does the evidence show that prokinetic agents are effective in healing esophagitis and improving symptoms of GERD?

Gastroesophageal reflux disease (GERD) is common in affluent societies, and its prevalence is also on the rise in developing regions such as Southeast Asia.1 When heartburn and regurgitation are the dominant symptoms, a diagnosis of GERD can be made. Manzotti and colleagues report in Open Medicine t...

Descripción completa

Detalles Bibliográficos
Autores principales: Looijer-van Langen, Mirjam, Veldhuyzen van Zanten, Sander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Medicine Publications, Inc. 2007
Materias:
Analysis and Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113219/
https://www.ncbi.nlm.nih.gov/pubmed/21673950
Descripción
Sumario:Gastroesophageal reflux disease (GERD) is common in affluent societies, and its prevalence is also on the rise in developing regions such as Southeast Asia.1 When heartburn and regurgitation are the dominant symptoms, a diagnosis of GERD can be made. Manzotti and colleagues report in Open Medicine the findings of a systematic review in which they evaluate the use of prokinetic agents in the treatment of reflux esophagitis.

Ejemplares similares